Pharmacogenomics: prospects towards customized therapeutics

Individualized Medicine is more than just a metabolic activity of a individual. Pharmacogenomics, pharmacogenetics, pharmacoproteomics, and metabolomics play a principal part in the development of individualized medicines. Individualized /Personalized medicine uses information about a person's genes, proteins, enzyme activities, and cellular environment to diagnose and treat disease. A major problem of individualized medicine is the fact that there is no portablebed side and low-cost bio-analytical technology that can be used in close proximity to the patient. This technology could play a significant role in defining the dosage setting for subsets of the population. The success of the individualized therapeutic is possible through the application of technology, which can provide a bridge between metabolism profiles and an individual's response to a particular drug and therapeutic modality.

Autorentext

Dr. Mohammad Nadeem Khan is a distinguished medical researcher, academic, and clinical trial expert with extensive expertise in ethnopharmacology, integrative medicine, and drug discovery. With elite certification in New Drug and Clinical Trial Rules from IIT Madras.